Newsfeed

RARE BRAIN DISEASE RESEARCHERS TO RECEIVE MORE THAN $30 MILLION IN FUNDING OVER NEXT 5 YEARS

Researchers studying frontotemporal degeneration (FTD) disease, a leading cause of early onset dementia, will receive more than $30 million over the next five years in grants from the National Institutes of Health (NIH). The funding will be used to further scientific collaboration and investigate new treatments in the quest to find a cure for FTD. Click here to read full release.

Porter Road Butcher Fights FTD

AFTD’s friends at Porter Road Butcher hosted a Food for Thought event for the second year, donating 10% of the day’s profits and setting up tents outside to educate shoppers about FTD. Read the article here.

The Boston Globe ‘Health Answers’ Features FTD

AFTD Medical Advisory Council member Murray Grossman, M.D., Ed.D., helps The Boston Globe answer the question: “What is frontotemporal dementia, and is it inheritable?” Dr. Grossman is Director of the Penn Frontotemporal Degeneration Center and a University of Pennsylvania professor. Click here to read the article.

A Wife’s Death Means a New Beginning

In this blog, Dan Browning, who writes about health care and medical research for the Star Tribune in Minneapolis, describes the aftermath of his wife’s recent death from complications related to FTD.  Click here to read the full article.

 

Changes in Eye Can Predict Changes in Brain

Researchers have shown that loss of cells in the retina is one of the earliest signs of FTD in people with a genetic risk. Click here to read the full article.